Preliminary Program subject to change
Functional Proteomics, Cell Signaling and Disease Biomarkers
Presentation Type	Oral
Summary Statement
Novel Multiplexed CSF Biomarkers for Antemortem Alzheimer's Diagnosis Kelvin H. Lee, Erin Finehout, Zsofia Franck, Leila Choe and Norman Relkin, Cornell University, Ithaca, NY Serum peptide signatures of solid tumor cancers Paul Tempst and Josep Villanueva, Memorial Sloan-Kettering Cancer Center, New York, NY A Mass Spectrometry-Based Quantitative View of Protein Phosphorylation Roland S. Annan, Francesca Zappacosta, Dean McNulty, Micheal Huddleston and Therese Sterner, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA Break The identification of possible blood proteins as biomarkers for atherosclerotic plaque Stanley A. Hefta, Bristol Myers Squibb Co., Princeton, NJ Functional Proteomics of Ephrin Signaling Thomas A. Neubert, Daniel S. Spellman and Guoan Zhang, New York University School of Medicine, New York, NY

General Submissions